Targeted reprogramming of tumor-associated macrophages for overcoming glioblastoma resistance to chemotherapy and immunotherapy
Jianan Li(Beijing Institute of Technology), Shaobo Ruan(American Association of Colleges of Pharmacy), Yuanyu Huang(Beijing Institute of Technology), Guang‐Yao Ran(Sichuan University), Bo Hu(Beijing Institute of Technology), Yuquan Zhang(Affiliated Hospital of Nantong University), Lin Xu(Beijing Institute of Technology), Jun Yang(Beijing Institute of Technology), Yunxin Tian(Beijing Institute of Technology), Shaoping Jiang(Beijing Institute of Technology), Zhaohan Li(Beijing Institute of Technology), Huiping Shi(Beijing Institute of Technology)
Cited by 48
Related Papers
Therapeutic siRNA: state of the art
|Signal Transduction and Targeted Therapy|2020|1.5k
Estrogen-related Receptor, hERR1, Modulates Estrogen Receptor-mediated Response of Human Lactoferrin Gene Promoter
|Journal of Biological Chemistry|1996|198
Rethinking CRITID Procedure of Brain Targeting Drug Delivery: Circulation, Blood Brain Barrier Recognition, Intracellular Transport, Diseased Cell Targeting, Internalization, and Drug Release
|Advanced Science|2021|188